Home Page - Icthic Magazine

LATEST ARTICLES

Is apixaban safe for primary VTE prevention in patients with gastrointestinal cancers? A summary of a post-hoc analysis of the AVERT trial

Patients with cancer and a Khorana score ≥2 have an estimated risk of symptomatic venous thromboembolism (VTE) of...

Does the use of direct oral anticoagulants improve adherence compared to low-molecular-weight heparin (LMWH) in patients with cancer?

Patients with cancer represent a major challenge for venous thromboembolism (VTE) treatment because of their higher...

Differences in thromboprophylaxis between hospitalized patients with solid or hematological malignancies: A talk with Prof. Páramo

José Antonio Páramo is a Professor of Hematology at the University Clinic of Navarra, University of Navarra,...

Risk assessment models for venous thromboembolism in ambulatory patients with cancer: A talk with Prof. Gerotziafas

Prof Gerotziafas is a specialist in thrombosis and hemostasis with a particular interest in cancer-associated...

Cancer-associated thrombosis in the pediatric setting: A chat with Prof. Gili Kenet

Prof. Gili Kenet is a Pediatric Hematologist, Professor and Chair of the Haematology Department at the Sackler Medical...

Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger

Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...

FEATURED VIDEO

ISTH 2019: The CAT treatment, from trials to clinical practice by ICTHIC Editorial Office 29 July 2019

The big Gary Raskob interview by ICTHIC Editorial Office 24 September 2018

An interview with Grigorios Gerotziafas by ICTHIC Editorial Office 11 September 2018

ISTH 2018 – Anna Falanga by ICTHIC Editorial Office 3 August 2018

None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue